Literature DB >> 23357663

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are not useful in heart failure management: the art of medicine remains long.

Akshay S Desai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23357663     DOI： 10.1161/CIRCULATIONAHA.112.120493

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.

Authors:  Raffaele Altara; Marco Manca; Marleen H Hessel; Yumei Gu; Laura C van Vark; K Martijn Akkerhuis; Jan A Staessen; Harry A J Struijker-Boudier; George W Booz; W Matthijs Blankesteijn
Journal:  J Cardiovasc Transl Res       Date:  2016-06-06       Impact factor: 4.132

Review 2.  Circulating biomarkers in patients with heart failure and preserved ejection fraction.

Authors:  Eileen O'Meara; Simon de Denus; Jean-Lucien Rouleau; Akshay Desai
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 3.  GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study.

Authors:  Kenneth B Margulies; Kevin J Anstrom; Adrian F Hernandez; Margaret M Redfield; Monica R Shah; Eugene Braunwald; Thomas P Cappola
Journal:  Circ Heart Fail       Date:  2014-07       Impact factor: 8.790

4.  Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.

Authors:  Shivanand Shankar Medar; Daphne T Hsu; H Michael Ushay; Jacqueline M Lamour; Hillel W Cohen; James S Killinger
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

Review 5.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 6.  The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study.

Authors:  Nasrien E Ibrahim; James L Januzzi
Journal:  Curr Heart Fail Rep       Date:  2018-04

Review 7.  Redefining the role of biomarkers in heart failure trials: expert consensus document.

Authors:  Frank Kramer; Hani N Sabbah; James J Januzzi; Faiez Zannad; J Peter van Tintelen; Erik B Schelbert; Raymond J Kim; Hendrik Milting; Richardus Vonk; Brien Neudeck; Richard Clark; Klaus Witte; Wilfried Dinh; Burkert Pieske; Javed Butler; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

Review 8.  Current Role of the CardioMEMS Device for Management of Patients with Heart Failure.

Authors:  Calvin C Leung
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 9.  Charting a roadmap for heart failure biomarker studies.

Authors:  Tariq Ahmad; Mona Fiuzat; Michael J Pencina; Nancy L Geller; Faiez Zannad; John G F Cleland; James V Snider; Stephan Blankenberg; Kirkwood F Adams; Rita F Redberg; Jae B Kim; Alice Mascette; Robert J Mentz; Christopher M O'Connor; G Michael Felker; James L Januzzi
Journal:  JACC Heart Fail       Date:  2014-06-11       Impact factor: 12.035

10.  Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure.

Authors:  Miki Imazu; Hiroyuki Takahama; Makoto Amaki; Yasuo Sugano; Takahiro Ohara; Takuya Hasegawa; Hideaki Kanzaki; Toshihisa Anzai; Naoki Mochizuki; Hiroshi Asanuma; Masanori Asakura; Masafumi Kitakaze
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.